These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38142583)

  • 1. Excessive SOX8 reprograms energy and iron metabolism to prime hepatocellular carcinoma for ferroptosis.
    Yang X; Gu C; Cai J; Li F; He X; Luo L; Xiao W; Hu B; Hu J; Qian H; Ren S; Zhang L; Zhu X; Yang L; Yang J; Yang Z; Zheng Y; Huang X; Wang Z
    Redox Biol; 2024 Feb; 69():103002. PubMed ID: 38142583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of FGFR4 signaling by F30 inhibits hepatocellular carcinoma cell proliferation through HMOX1-dependent ferroptosis pathway.
    Huang F; Shi X; Hu M; Yan H; Li X; Ding Y; Zheng X; Cai X; Dai S; Xia Q; Cai Y
    Eur J Pharmacol; 2024 May; 970():176493. PubMed ID: 38484925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway.
    Chen J; Zhang J; Tian W; Ge C; Su Y; Li J; Tian H
    Mol Carcinog; 2023 Jun; 62(6):833-844. PubMed ID: 36920042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma.
    Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J
    Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MVP enhances FGF21-induced ferroptosis in hepatocellular carcinoma by increasing lipid peroxidation through regulation of NOX4.
    Xia J; Fu B; Wang Z; Wen G; Gu Q; Chen D; Ren H
    Clin Transl Sci; 2024 Aug; 17(8):e13910. PubMed ID: 39143889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
    Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
    J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells.
    Shang Y; Luo M; Yao F; Wang S; Yuan Z; Yang Y
    Cell Signal; 2020 Aug; 72():109633. PubMed ID: 32283255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis.
    Huang Q; Li J; Ma M; Lv M; Hu R; Sun J; Zhong X; Sun X; Feng W; Ma W; Zhang W; Zhan B; Han Z; Zhou X
    Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36825585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
    Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
    Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel sesquiterpene lactone fraction from Eupatorium chinense L. suppresses hepatocellular carcinoma growth by triggering ferritinophagy and mitochondrial damage.
    Zhu ZH; Xu XT; Shen CJ; Yuan JT; Lou SY; Ma XL; Chen X; Yang B; Zhao HJ
    Phytomedicine; 2023 Apr; 112():154671. PubMed ID: 36773432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma.
    Zhou L; Zhang Q; Cheng J; Shen X; Li J; Chen M; Zhou C; Zhou J
    Drug Discov Ther; 2023 Sep; 17(4):248-256. PubMed ID: 37599085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
    Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
    Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis.
    Hu W; Zhou C; Jing Q; Li Y; Yang J; Yang C; Wang L; Hu J; Li H; Wang H; Yuan C; Zhou Y; Ren X; Tong X; Du J; Wang Y
    Cancer Cell Int; 2021 Dec; 21(1):709. PubMed ID: 34965856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
    Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
    Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ferroptosis in hepatocellular carcinoma.
    Mo Y; Zou Z; Chen E
    Hepatol Int; 2024 Feb; 18(1):32-49. PubMed ID: 37880567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility.
    Cui X; Yun X; Sun M; Li R; Lyu X; Lao Y; Qin X; Yu W
    Hepatol Int; 2023 Apr; 17(2):377-392. PubMed ID: 36508088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation.
    Shi Z; Li Z; Jin B; Ye W; Wang L; Zhang S; Zheng J; Lin Z; Chen B; Liu F; Zhang B; Ding X; Yang Z; Shan Y; Yu Z; Wang Y; Chen J; Chen Q; Roberts LR; Chen G
    Clin Transl Med; 2023 Jun; 13(6):e1300. PubMed ID: 37337470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis.
    Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
    Cell Biol Int; 2020 Nov; 44(11):2344-2356. PubMed ID: 32808701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.